Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03801694 · ClinicalTrials.gov registry record
Predicting the Development of Myocardial Depression in Acute Neurological Patients
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 4
- Enrollment target
NCT03801694 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 4 participants.
The verdict
NCT03801694 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the levels of serum catecholamines associated with myocardial depression (MD) in patients with acute neurological injury.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-12-03 |
| Est. Completion | 2024-04-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03801694
The ClinicalTrials.gov registry entry for NCT03801694 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03801694 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03801694 about?
NCT03801694 is a clinical study titled "Predicting the Development of Myocardial Depression in Acute Neurological Patients". The purpose of this study is to assess the levels of serum catecholamines associated with myocardial depression (MD) in patients with acute neurological injury.
What is the current status of trial NCT03801694?
This trial is currently completed. The enrollment target is 4 participants. The study started on 2018-12-03. Estimated completion is 2024-04-14.
Who is sponsoring clinical trial NCT03801694?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.